Last reviewed: July 6, 2026 Last updated: July 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
AOD-9604 acts by decomposing stored fat, particularly in stubborn areas, and can result in noticeable fat reduction with daily use over several weeks
The most recent study from France titled GLP-1 receptor agonists and the risk of thyroid cancer (2) concluded that there was, in fact, an increased risk of all thyroid cancer and medullary thyroid cancer with the use of GLP-1 receptor agonists, in particular after 1-3 years of treatment
Respiratoire et pulmonaire
while G6PD status is not measured by a standard CBC, abnormal RBC morphology can surface when hemolysis is active and is worth tracking in context
These effects directly intersect with pathways implicated in colorectal carcinogenesis